MV
Merryn Voysey
University of Birmingham, University of Oxford
Research areas: Medicine · Infectious Diseases · Bacterial Infections and Vaccines · SARS-CoV-2 and COVID-19 Research · Pneumonia and Respiratory Infections
Employment
-
University of Birmingham 125th Anniversary Chair2026 - Present
Education
Education history is unavailable.
Projects & Funding
-
Early MCV1 efficacy study Gates Foundation2025 - 2029
-
Group B Streptococcus Burden of Disease Estimates Gates Foundation2025 - 2028
-
PReparing for Optimal Phase III/IV maTErnal Group B StreptococCal vaccine Trials in Africa UK Research and Innovation2024 - 2027
-
Modelling Vaccine Efficacy for Group B Streptococcus Gates Foundation2024 - 2026
-
Moving maternal Group B Streptococcal vaccines into clinical effectiveness trials. UK Research and Innovation2023 - 2026
-
Defining correlates of protection for Group B streptococcus infections Gates Foundation2023 - 2025
-
Experimentally induced blood-stage malaria in Kenyan adults: understanding disease mechanisms and protection in the context of background immunity Medical Research Council2022 - 2026
-
BoostMe: Immunogenicity of earlier prime-boost MR schedule in Uganda Bill and Melinda Gates Foundation2022 - 2027
-
TyVOID Wellcome Trust Ltd2021 - 2026
-
The immunogenicity and efficacy of pneumococcal vaccines: a systematic review and network meta-analysis of individual participant data NIHR Evaluation Trials and Studies Coordinating Centre2019 - 2023
-
Assessing and testing multivariate meta-analysis methods to improve the precision of studies with multiple correlated outcomes the example of vaccine trials National Institute for Health and Care Research2015 - 2019
Publications (188)
- Measles in Ugandan Children Under 18 Months of Age: A Retrospective Study of Case-based Surveillance, 2018–2024 Save
- Maternal iron status and total immunoglobulin-G influence transplacental antibody transfer across eight diverse geographical settings Save
- Seroefficacy of a 10-Valent Pneumococcal Conjugate Vaccine (Pneumosil®) Compared with Other Pneumococcal Conjugate Vaccines in Children Save
- Modeling Indirect Protection from Typhoid Conjugate Vaccines in the TyVAC-Bangladesh Trial Save
- A novel approach for estimating vaccine efficacy for infections with multiple outcomes: application to a COVID-19 vaccine trial Save
- A statistical method for evaluating vaccine-induced immune correlates of protection against infection and disease progression: application to the ChAdOx1-S nCoV-19 phase 3 trial Save
- Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222) Save
- Epidemiology of Group B Streptococcus: Maternal Colonization and Infant Disease in Kampala, Uganda Save
- Etiology and Antimicrobial Resistance of Culture-Positive Infections in Ugandan Infants: A Cohort Study of 7000 Neonates and Infants Save
- Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil Save
- Interplay between the gut microbiome and typhoid fever: insights from endemic countries and a controlled human infection model Save
- Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study Save
- Mass testing for discovery and control of COVID-19 outbreaks in adult social care: an observational study and cost-effectiveness analysis of 14 805 care homes in England Save
- PROTECTION CONFERRED BY A SINGLE DOSE OF TYPHOID CONJUGATE VACCINE AMONG BANGLADESHI CHILDREN AFTER FIVE YEARS OF VACCINATION: ANALYSIS OF A CLUSTER RANDOMIZED CONTROLLED TRIAL Save
- Placental transfer of SARS-CoV-2 antibodies in mother-neonate pairs: a prospective nested cohort study Save
- Predictors of severity of SARS-CoV-2 infections in Brazil: Post hoc analyses of a randomised controlled trial Save
- Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study Save
- The validity of test-negative design for assessment of typhoid conjugate vaccine protection: comparison of estimates by different study designs using data from a cluster-randomised controlled trial Save
- The waning of maternal measles antibodies: A multi-country maternal-infant seroprevalence study Save
- What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health Organization Save